Kura Oncology, Inc.
NASDAQ:KURA · NASDAQ Global Select
+$0.07 today
Vol 1.54M · Avg 1.66M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+69.17%
Period High
$12.14
Period Low
$5.54
Latest
$9.93
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Tango Therapeutics, Inc.
NASDAQ:TNGX
$3.51B
Tyra Biosciences, Inc.
NASDAQ:TYRA
$1.67B
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$1.27B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.13B
Savara Inc.
NASDAQ:SVRA
$1.11B
Replimune Group, Inc.
NASDAQ:REPL
$841.41M
Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
$732.01M
Prime Medicine, Inc.
NASDAQ:PRME
$566.24M
Rezolute, Inc.
NASDAQ:RZLT
$488.68M
ProKidney Corp.
NASDAQ:PROK
$261.88M
What is the latest KURA filing?
The latest filing shown is 4 dated Jun 4, 2026.
How many recent filings does KURA have?
Intrinsic Alpha currently shows 20 recent filings for KURA.
Explore More
Continue the stock analysis
Jump to another research area for this company.